Literature DB >> 15853596

Management of obesity cardiomyopathy.

Martin A Alpert1, Matthew A Fraley, Jessica A Birchem, Neelavathi Senkottaiyan.   

Abstract

Obesity causes a variety of hemodynamic alterations that may lead to changes in cardiac structure and function. Although such abnormalities may occur in patients with mild-to-moderate obesity, they are most pronounced in those with morbid obesity. When these alterations produce congestive heart failure, obesity cardiomyopathy is said to be present. In this review, the authors will first discuss the pathogenesis and clinical manifestations of obesity cardiomyopathy and then describe the management of this clinical syndrome with emphasis on the effects of weight reduction.

Entities:  

Mesh:

Year:  2005        PMID: 15853596     DOI: 10.1586/14779072.3.2.225

Source DB:  PubMed          Journal:  Expert Rev Cardiovasc Ther        ISSN: 1477-9072


  3 in total

Review 1.  Use of metformin in diseases of aging.

Authors:  John M Miles; Andrew D Rule; Barry A Borlaug
Journal:  Curr Diab Rep       Date:  2014-06       Impact factor: 4.810

2.  Asymmetric left ventricular hypertrophy associated with morbid obesity mimicking familial hypertrophic cardiomyopathy.

Authors:  Raymond Ching-Chiew Wong; Kong Bing Tan
Journal:  Singapore Med J       Date:  2014-12       Impact factor: 1.858

Review 3.  Mechanisms of heart failure in obesity.

Authors:  Imo A Ebong; David C Goff; Carlos J Rodriguez; Haiying Chen; Alain G Bertoni
Journal:  Obes Res Clin Pract       Date:  2014-01-06       Impact factor: 2.288

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.